MAP kinase in the murine bone marrow-derived cell line BAF3. This results in an increase in the level of IL-3 required to stimulate cell proliferation and suppress apoptosis. When apoptosis is constitutively inhibited by coexpression of bcl-2, the dominant interfering MAPKK inhibits IL-3-driven cell cycle progression. Thus, MAPKK function is necessary for EMATOPOIESIS is the process of proliferation and H differentiation of stem cells and their progeny that gives rise to the mature lineages that constitute the hematopoietic system. The early stages of this process occur in the microenvironment of the bone marrow (BM), where stromal cells and neighboring hematopoietic cells provide both cellassociated and soluble growth and survival factors. One such growth factor is the cytokine interleukin-3 (IL-3), which can promote the proliferation and differentiation of both early progenitors and more mature cells.' IL-3 acts by binding to specific cell surface receptors composed of two chains, the IL-3-specific-a chain and the signal transducing-P-common chain (AIC2B).*
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The signal transduction processes stimulated by the IL-3 receptor and other hemopoietin receptors are similar to those triggered by tyrosine kinase receptors. Thus, although the IL-3 receptor does not possess intrinsic tyrosine kinase activity, ligand stimulation leads to the rapid phosphorylation of many proteins on tyr~sine.'.~ Several tyrosine kinases have been identified that interact directly with the cytoplasmic tail of the IL-3 receptor,*a9 or are activated by IL-3." One consequence of tyrosine kinase action is Shc phosphorylation" and the stimulation of nucleotide exchange factors that result in the guanosine triphosphate loading of r a~. *~-'~ Cytokine stimulation also results in the activation of raf and MAP k i n a~e . '~-'~ In fibroblasts, the activation of ras, raf, MAP kinase kinase (MAPKK) and MAP kinase appears to be a linear pathway that is stimulated by growth factor receptors and leads to cell proliferation." Thus, constitutive activation of MAP kinase has been shown to be sufficient for the proliferation of NIH3T3 cells. 20 In contrast, constitutive activation of the ras pathway in the phaeochromocytoma cell line PC 12 leads to their differentiatiom2 ' In hematopoietic cells, the role of the ras pathway in cell proliferation, differentiation, and survival is less clear. In particular IL-2 and IL-3 receptor mutants have been reported that fail to activate the ras pathway and yet appear capable of delivering a full proliferative ~i g n a l . '~.~' These mutant receptors are capable of activating JAK family tyrosine kin a s e~~,~~ and stimulating expression of myc. 17, 23 Therefore it has been suggested that activation of these pathways is sufficient to stimulate proliferation of cytokine-dependent hematopoietic cells. Indeed, it has been shown that inhibition of JAK 2 kinase using a dominant interfering mutant can block erythropoietin stimulated mitogene~is. ~~ We were prompted to evaluate the role of the MAP kinase kinase step of the ras pathway by the observation that activaoptimal IL-3 inhibition of apoptosis and optimal IL-3 stimulation of entry into S phase. Expression of a constitutively activated mutant of MAPKK does not replace IL-3, but renders cells able to proliferate in a density-dependent manner. Cell contact is required to allow cell proliferation; such contact can be supplied by cells without activated MAPKK. 0 1996 by m e American Society of Hematology.
tion of its target MAP kinase correlated with the ability of IL-2 and IL-3 to stimulate proliferation.2s In this report we have investigated the function of MAPKK in IL-3 driven proliferation by the use of either dominant negative or constitutively active mutants of MAPKK. Cell lines expressing these mutants show a role for MAPKK in IL-3 stimulated proliferation.
MATERIALS AND METHODS
BAF3 cells2' and their derivatives were cultured in Dulbecco's modified Eagle's medium (DMEM) with 10% fetal calf serum (FCS) and 5% WEHI 3B cell-conditioned medium as a source of IL-3. Cells were cultured at a density below 4 X 10' cells/ mL in a 10% C02 humidified incubator.
Cell lines expressing MAPKK were constructed as follows: BamHI/Sall fragments encoding MAPKK mutants were excised from pBABEpuro'" and inserted into pEF-BOS2' to generate pEF-W-MAPKK containing wild type MAPKK, pEF-DN-MAPKK containing the dominant negative MAPKK, and pEF-A-MAPKK containing the constitutively activated MAPKK, as described." These vectors were coelectroporated in Gene Pulser Cuvettes (Bio-Rad Laboratories, Richmond, CA) at a IO:] ratio with the vector pBABEpuro into BAF3 cells or a derivative expressing h~1-2'~ using a gene pulser (Bio-Rad) with capacitance extender. Cells were electroporated with 300 volts, 960 mF. Single cell clones were isolated at limiting dilution with selection by 4 pg/mL puromycin and maintained for further analysis.
To remove IL-3, cells were washed twice in DMEM/10% FCS. For proliferation and viability assays cells were then plated in 96-well microtiterplates in 100-pL aliquots at 1 X lo5 cells/mL or at the density stated and with the concentration of IL-3 conditioned medium indicated. Cellconditioned medium from transfected plasmacytoma cellsz9 was used as a source of IL-3 for these assays. Alternatively where stated,
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'feeder' cells that expressed bcl-2 and which had been previously irradiated with 2,000 rads of x-rays to prevent their subsequent proliferation were plated with the target cells. Cell irradiation was performed using a Pantac x-ray machine (Pantak Ltd, Windsor, Berkshire, UK) with an output of 240 keV at a dose rate of 250 to 300 rads/min. After the time stated proliferation was determined by a 4-hour pulse with 0.5 pCi 3H-thymidine and cells harvested using a Dynatech cell harvester (Dynatech Labs Ltd, Sussex, UK). Altematively cell viability was determined by counting viable versus dead cell numbers on a heamacytometer using a phase contrast microscope. For the detection of apoptosis and cell cycle analysis, washed cells were plated in 1 mL aliquots at 1 X IO5 cells/mL in 24 well tissue culture plates with the concentrations of IL-3 conditioned medium indicated. After the time stated cells were pelleted and fixed in ice cold 70% ethanoV30% phosphate buffered saline (PBS). Fixed cells were pelleted, resuspended in PBS containing 100 pg/mL RNAase and 40 pg/mL propidium iodide and incubated for 30 minutes at 37°C. The fluorescence of the stained cells was analyzed using the software Lysis I1 (Becton Dickinson, San Jose, CA) on a FACScan (Becton Dickinson). The extent of apoptosis within cultures was determined to be the proportion of cells within the sub GI peak to cells in the rest of the cell cycle, as previously described.'" Measurement of MAPKK expression and MAP kinase activity. Cells were stimulated and extracts prepared as described.25 Cellconditioned medium from transfected plasmacytoma cells" at a supersaturating concentration was used as a source of IL-3. Briefly, 4 X IO6 cells per sample were stimulated and cell pellets made to 20 mmoVL Tris pH 8.0,40 mmoVL N&P,O,, 50 mmoVL NaF, 5 mmol/ L MgClz, 100 mmollL Na3VO4, IO mmoVL EDTA, 1% Triton X-100,0.5% sodium deoxycholate, 10 pg/mL antipain, IO pg/mL elastinal, IO pg/mL leupeptin, 50 pg/mL aprotonin, 20 pg/mL pepstatin A and 0.5 mmol/L phenylmethylsulfonyl fluoride (PMSF). Thirty micrograms of protein per sample was separated by discontinuous sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and Westem blots probed with anti-erk2 antiserum (antiserum 122) and anti-MAPKKI antiserum (antiserum 179) as de~cribed.~'
RESULTS
Expression of a dominant negative MAPKK inhibits IL-3 driven proliferation. Previously, we have shown that both IL-2 and IL-3 can stimulate the rapid and sustained activation of MAP kinase in the BM derived IL-3 dependent progenitor cell line BAF3. This activation of MAP kinase correlated with BAF3 cell pr~liferation.'~ Here, we have investigated the role of MAP kinase in BAF3 cell proliferation by blocking its activation on IL-3 stimulation. MAP kinase is activated by the dual specificity kinase MAPKK. To block MAP kinase activation on IL-3 stimulation, we used a defined interfering mutation of MAPKK. The mutation of serine 217 or 221 to alanine of MAPKK-1 results in a mutant molecule that is unable to be activated by raf-1 in vitro3' and can block the activation of MAP kinase by epidermal growth factor (EGF) when expressed in COS cells?0 NIH3T3 cells stably expressing this dominant negative MAPKK (DN-MAPKK) show a slower growth rate in low concentrations of serum, indicating a requirement for MAP kinase activation in NIH3T3 cell growth."
To achieve high levels of expression of MAPKK molecules in BAF3 cells, we used the powerful elongation factor promoter contained within the pEF-BOS expression vector.27
Vector containing DN-MAPKK (pEF-DN-MAPKK) was coelectroporated into BAF3 cells with the vector pBABE-PURO." As controls, empty vector (pEF) and vector containing wild type MAPKK (pEF-W-MAPKK) were also cotransfected with pBABEPUR0. The inclusion of pBABEPUR0 provided expression of the puromycin resistance gene such that single cell clones could be isolated at limiting dilution by selection in puromycin. The frequency of stable cell production was similar for all three vectors, with at least 80% of the clones obtained with either pEF-W-MAPKK, or pEF-DN-MAPKK expressing MAPKK as determined by Western blot with a specific MAPKK antibody (data not shown). Therefore the DN-MAPKK is not lethal to BAF3 cells at the expression levels achieved with the pEF-BOS vector.
Clones expressing the highest levels of wild type or DN-MAPKK, as identified by Western blot with the anti-MAPKK antibody, were analysed further. The expression of MAPKK for a representative clone of cells expressing wild type (BO-W5) or dominant negative (BO-D16) MAPKK can be seen in Fig 1A. The expression level of the DN-MAPKK is equivalent to that of the wild type. Both proteins are expressed at considerably higher levels than endogenous MAPKK-1, which cannot be seen on this exposure ( Fig 1A) though their abundance relative to total endogenous MAPKK protein remains undetermined as MAPKK-2 is not detected by this antibody. To confirm that MAP kinase activation was inhibited by expression of DN-MAPKK in BAF3 cells, the ability of IL-3 to stimulate MAP kinase activity was determined. Cells were deprived of IL-3 for 2 hours and then restimulated with a supersaturating level of IL-3 for 10 minutes. The result of a typical experiment is shown in Fig 1A; MAP kinase activation is measured by a gel mobility shift, where the lower mobility form represents phosphorylated, activated MAP kinase. Whereas cells with empty vector (BO-E) or expressing W-MAPKK (BO-W5) show a strong MAP kinase stimulation, cells expressing the DN-MAPKK (BO-D 16) displayed a depressed activation in response to IL-3. It should be noted that some activated MAP kinase is still detected in the cells stably expressing the DN-MAPKK, when they are stimulated with this high level of IL-3. Thus expression of the DN-MAPKK in BAF3 cells results in reduced MAP kinase activation in response to IL-3.
Next, the IL-3 stimulated proliferation of BAF3 cells expressing DN-MAPKK was examined in detail. Proliferation in response to varying concentrations of IL-3 was determined after 24 hours by ['HI-thymidine incorporation. Although the maximal proliferation displayed by each cell line was similar, three cell clones expressing the DN-MAPKK showed an inability to proliferate in suboptimal concentrations of IL-3. This result for a representative cell clone, BO-D16, is shown in Fig 1B. It can be seen that 10-fold more IL-3 is required to stimulate half maximal proliferation in the cells expressing DN-MAPKK. An identical result was obtained using recombinant IL-3. Thus 0.94U/mL recombinant IL-3 stimulated half maximal thymidine incorporation in BO-E cells, whereas 9.6U/mL were required for BO-Dl6 cells. These data show that MAPKK function is required for the optimal stimulation of BAF3 cell proliferation by the IL-3 receptor.
MAPKKfirnction is required for both optimal inhibition of apoptosis and cell cyAe progression. Stimulation of BAF3 cells with IL-3 both drives the cell cycle and inhibits apoptosis. The ['HI-thymidine incorporation assay used to determine cell proliferation is dependent both on the number of cells in S phase and the total cell number at the time of assay. The decrease in ['HI thymidine incorporation when MAPKK was inhibited could therefore result from an inability of IL-3 to stimulate progression through the cell cycle or an inability to inhibit apoptosis. First, we determined whether MAPKK was required for IL-3 to inhibit apoptosis. To accurately quantitate apoptosis within BAF3 cell cultures the proportion of cells within a sub GI peak was compared to those in the rest of the cell cycle.'" It can be seen in Fig IC that cells expressing the DN-MAPKK (BO-DI 6) require higher concentrations of IL-3 to inhibit apoptosis. These data show that activation of MAPKK by IL-3 is required for optimal suppression of apoptosis in BAF3 cells. Next, we determined whether MAPKK is required for progression through the cell cycle. To prevent entry into apoptosis, we constructed cells that expressed both dominant negative MAPKK and the oncogene bcl-2. Previously, we have shown that overexpression of bcl-2 prevents the induction of apoptosis when IL-3 is withdrawn from BAF3 cells, but does not allow proliferation.'x Like the cells expressing bcl-2 alone, those expressing bcl-2 and dominant negative MAPKK (BCL-D8) survived for at least 72 hours in the absence of IL-3 (data not shown), but failed to proliferate (Fig 2B and C) . IL-3 stimulated MAP kinase activity in these cells was repressed to a similar extent to that in the non bcl-2 expressing clones (Fig 2A) . Analysis of the proliferation of BCL-D8 showed that they required higher concentrations of IL-3 to proliferate than cells expressing empty vector (BCL-El) or wild type MAPKK (BCL-WII) (Fig 2B) . Likewise, BCL-E1 cells incorporated half maximal thymidine when stimulated with 0.36 U/mL recombinant IL-3 whereas BCL-D6 cells required 4.7 U/mL. The fact that inhibition of MAPKK leads to a decrease in the IL-3 responsiveness of these bcl-2 expressing clones indicates that MAPKK activity influences how BAF3 cells proliferate in response to IL-3. The availability of cells expressing both bcl-2 and DN-MAPKK allowed us also to investigate the requirement for MAPKK in IL-3 stimulated re-entry into the cell cycle as such cells can be arrested in GO by the removal of cytokine.2x Fig 2C shows that the cell clone expressing dominant negative MAPKK required higher concentrations of IL-3 to re-enter the cell cycle. The expression of the dominant negative MAPKK did not affect the rate of proliferation of cells in optimal IL-3, or their cell cycle distribution when proliferating in optimal IL-3 ( Fig 2D) . This data shows that MAPKK activation by IL-3 plays a role in entry into the cell cycle. Figure 3A shows the proliferation of typical clones of cells 48 hours after seeding in the absence of factor at a variety of densities. Cells expressing A-MAPKK (BO-A2) proliferated at densities above 1 x 10' cells/mL, whereas control cells (BO-E) or cells expressing W-MAPKK (BO-WS) behaved in an identical fashion to parental cells and could not grow at any density. Cell survival was also determined by the cell density (Fig 3B) . The cells expressing A-MAPKK and bcl-2 (BCL-AIS) also showed density dependent proliferation; cooperation was evident between bcl-2 and A-MAPKK to produce proliferation at lower cell densities (Fig 3A) . However, these cells were still unable to grow continuously in culture when plated at an initial density below l X IO"/mL (Fig 3C) . The cooperation between A-MAPKK and bcl-2 can be explained by inhibition of cell death by bcl-2 which maintains a higher cell density and therefore stimulates proliferation.
These observations explain why we were unable to isolate IL-3 independent cells directly, following electroporation of pEF A-MAPKK into BAF3 cells, or BAF3 cells expressing bcl-2 (data not shown), because A-MAPKK was not sufficient to drive proliferation of BAF3 cells. However, in contrast to fibroblasts, constitutive activation of MAP kinase could not be detected in the selected clones expressing A-MAPKK, either by mobility decrease on SDS-PAGE or by immunoprecipitation and kinase assay (data not shown). As MAPKK acts directly on MAP kinase it seems likely that a high level of MAP kinase phosphatase activity may prevent detection of MAP kinase activation by A-MAPKK in BAF3 cells.
Tlie density dependent proliferation is a result of sensitization by A-MAPKK to a paracrine growth signal. Two mechanisms might explain the density dependent proliferation of the cells expressing A-MAPKK. The first production of a growth factor might be stimulated by A-MAPKK, which when sufficiently concentrated could promote cell growth. Alternatively, expression of A-MAPKK could result in cells that were hyperresponsive to a constitutively produced growth signal. To distinguish between these possibiliyties, we took advantage of the fact that the cell clones expressing bcl-2 could be used as 'feeders' to stimulate target cells. BAF3 cells expressing bcl-2 and irradiated with 2,000 rads remain viable in the absence of factor for at least 48 hours but are unable to proliferate when stimulated with IL-3 (data not shown). Figure 4 shows that bcl-2 expressing 'feeder' cells containing empty vector, wild type or A-MAPKK were able to provide an identical density dependent stimulation to BAF3 target cells expressing A-MAPKK (BO-A2). In contrast, no response is seen in the target cells containing W-MAPKK (BO-W5) or empty vector (not shown). Therefore it appears that there is no difference in the ability of parental or cells expressing A-MAPKK in ability to produce the stimulant that leads to density dependent growth. Rather it is the ability to respond that is critical. Therefore, A-MAPKK does not stimulate production of an autocrine growth factor, as was described for cells expressing activated r a~.~~ We were unable to stimulate proliferation of BAF3 cells expressing A-MAPKK by addition of Concentrated conditioned medium from any of the 'feeder' cell lines (data not shown). The expression of mutant cytokine receptors in BAF3 cells has identified regions in their cytoplasmic tails required for activation of the ras p a t h~a y . "~~' Such mutants of the IL-3 receptor chain AIC2B that fail to activate ras can only drive long-term proliferation when serum is present.34 The requirement for serum could be replaced by expression of a constitutively activated ras molecule35 showing that activation of ras is important for BAF3 cell growth. In this report we show that MAPKK activity is also important for optimal BAF3 cell growth. It is possible that MAPKK activation may be a critical target of ras in BAF3 cells, as it is in fibroblasts.*' Kinoshita et a135 suggested that the role of ras activation in BAF3 cell growth is to inhibit apoptosis, as opposed to promote cell cycle progression. In this report we show that activity of MAPKK is required for optimal inhibition of apoptosis. However, we have been further able to show that MAPKK activity is required for optimal cell cycle progression. It is possible that cell cycle arrest resulting from inhibition of MAP kinase induces apoptosis. Altematively MAPKK may activate separate pathways responsible for survival and cell cycle progression. A role of the ras pathway in the cell cycle progression of 1L-3 dependent cells was also demonstrated by Okuda et al, who show that the inducible expression of a dominant negative ras leads to the growth arrest of 32D cells grown in IL-3."
Although MAPKK was shown to be necessary for both survival and cell cycle progression of BAF3 cells, expression of activated MAPKK was insufficient to render BAF3 cells factor independent. It remains an open question as to whether sufficient constitutive MAP kinase activity might generate factor independent BAF3 cells as expression of A-MAPKK failed to promote detectable MAP kinase activity. Previous reports have shown that expression of activated ra~".".'~ or activated in IL-3 dependent cells does not render them factor independent, though it was not shown how much activation of a critical target such as MAP kinase was achieved. Expression of constitutively activated ras in BAF3 cells3' or constitutively activated raf in 32D cells39 has however been reported specifically to inhibit the induction of apoptosis when IL-3 is withdrawn. Likewise, in our experiments, BAF3 cells expressing A-MAPKK, plated at standard experimental conditions of 1 X lo5 cells/mL show a delay in the induction of apoptosis when IL-3 is removed. However, it seems likely that this is the result of a weak proliferative signal as these cells proliferate when plated at a higher cell density. In a similar fashion low concentrations of IL-3 promote only cell survival whereas higher concentrations are required for proliferation (Fig 1) . Whether this is the result of a requirement for greater stimulation of all signaling pathways to drive proliferation, rather than particular pathways being involved in survival versus proliferation is unclear at present.
The density dependent survival and proliferation of cells expressing A-MAPKK resulted from their becoming responsive to a growth factor expressed constitutively by BAF3 cells. Stimulation could not be transferred in conditioned medium, suggesting that this growth factor is either very labile or cell associated. Several other reports have shown that expression of signalling molecules can result in density dependent growth. Although many of these effects can be ascribed to the stimulation of secretion of a growth factor, for example stimulation of cytokine production by high levels of H-ras expression in mast cells," some studies conclude that a cell associated factor may be responsible. Thus, expression of v-ab1 in FDCP-mix cells:' or generation of v-myb expressing BM progenitor cells42 led to density dependent growth. These reports did not clarify whether such an effect was a result of increased expression of a cell associated factor, or a change in the responsiveness of the cells. The paracrine, cell-associated growth signal that we describe may play a role in the integration of external signals to regulate hematopoietic cell growth in BM. It could be supplied by neighboring hematopoietic cells or stromal cells. In this respect, it is intriguing that the growth of BAF3 cells expressing the A-MAPKK could be supported by NIH3T3 cells (data not shown), which can provide some stromal functions.
